Ocugen
OCGN
#7613
Rank
HK$2.98 B
Marketcap
HK$9.57
Share price
1.65%
Change (1 day)
38.32%
Change (1 year)

P/E ratio for Ocugen (OCGN)

P/E ratio as of December 2025 (TTM): -5.52

According to Ocugen's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -5.52273. At the end of 2024 the company had a P/E ratio of -3.93.

P/E ratio history for Ocugen from 2014 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024-3.93
2022-3.42-78.2%
2021-15.7
2017-2.0390.82%
2016-1.06-26.45%
2015-1.45-99.01%
2014-146

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
ORIC Pharmaceuticals
ORIC
-5.71 3.46%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.